Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Vasilena Zheleva"'
Autor:
Lauren L. Siewertsz van Reesema, Vasilena Zheleva, Janet S. Winston, Rick J. Jansen, Carolyn F. O’Connor, Andrew J. Isbell, Minglei Bian, Rui Qin, Patricia T. Bassett, Virginia J. Hinson, Kimberly A. Dorsch, Brad W. Kirby, Robert E. Van Sciver, Angela M. Tang-Tan, Elizabeth A. Harden, David Z. Chang, Cynthia A. Allen, Roger R. Perry, Richard A. Hoefer, Amy H. Tang
Publikováno v:
EBioMedicine, Vol 11, Iss C, Pp 183-198 (2016)
Background: Metastatic breast cancer exhibits diverse and rapidly evolving intra- and inter-tumor heterogeneity. Patients with similar clinical presentations often display distinct tumor responses to standard of care (SOC) therapies. Genome landscape
Externí odkaz:
https://doaj.org/article/65a73692ab8c408685ec6d1a14fec41e
Autor:
Gagan K. Gupta, Amber L. Collier, Dasom Lee, Richard A. Hoefer, Vasilena Zheleva, Lauren L. Siewertsz van Reesema, Angela M. Tang-Tan, Mary L. Guye, David Z. Chang, Janet S. Winston, Billur Samli, Rick J. Jansen, Emanuel F. Petricoin, Matthew P. Goetz, Harry D. Bear, Amy H. Tang
Publikováno v:
Cancers, Vol 12, Iss 9, p 2392 (2020)
Triple-negative breast cancer (TNBC), characterized by the absence or low expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), is the most aggressive subtype of breast cancer. TNBC accou
Externí odkaz:
https://doaj.org/article/01aa53826907478b914310880ae04d1e
Publikováno v:
Annals of Surgical Oncology. 27:2614-2625
To optimize breast cancer care, the American College of Surgeons Commission on Cancer developed quality measures regarding receipt and timing of adjuvant radiotherapy (RT). Nationwide compliance with these measures and its impact on overall survival
Autor:
Billur Samli, Lauren L. Siewertsz van Reesema, David Z. Chang, Harry D. Bear, Janet S. Winston, Amber L. Collier, Amy H. Tang, Matthew P. Goetz, Richard A. Hoefer, Emanuel F. Petricoin, Rick J. Jansen, Gagan K. Gupta, Vasilena Zheleva, Mary L. Guye, Dasom Lee, Angela M. Tang-Tan
Publikováno v:
Cancers, Vol 12, Iss 2392, p 2392 (2020)
Cancers
Cancers
Triple-negative breast cancer (TNBC), characterized by the absence or low expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), is the most aggressive subtype of breast cancer. TNBC accou
Autor:
Vasilena, Zheleva, Lily L, Lai
Publikováno v:
Annals of surgical oncology. 27(8)
Publikováno v:
Annals of surgical oncology. 27(8)
To optimize breast cancer care, the American College of Surgeons Commission on Cancer developed quality measures regarding receipt and timing of adjuvant radiotherapy (RT). Nationwide compliance with these measures and its impact on overall survival
Autor:
Lily L. Lai, Vasilena Zheleva
Publikováno v:
Annals of Surgical Oncology. 27:2626-2627
Autor:
Clayton Lau, Mustafa Raoof, Ioannis Konstantinidis, Byrne Lee, Kelly J. Lafaro, Vasilena Zheleva, Yuman Fong
Publikováno v:
Journal of robotic surgery. 14(3)
The application of robotic technology allows for the performance of multi-organ liver resections by multidisciplinary teams in a minimally invasive manner. Their technique and outcomes are not established. Herein we describe our technique with roboti
Autor:
Brad W. Kirby, Andrew J. Isbell, David Z. Chang, Virginia J. Hinson, Richard A. Hoefer, Robert E. Van Sciver, Carolyn F. O’Connor, Rick J. Jansen, Minglei Bian, Cynthia A. Allen, Vasilena Zheleva, Rui Qin, Patricia T. Bassett, Janet S. Winston, Angela M. Tang-Tan, Roger R. Perry, Amy H. Tang, Lauren L. Siewertsz van Reesema, Elizabeth A. Harden, Kimberly A. Dorsch
Publikováno v:
EBioMedicine, Vol 11, Iss C, Pp 183-198 (2016)
EBioMedicine
EBioMedicine
Background Metastatic breast cancer exhibits diverse and rapidly evolving intra- and inter-tumor heterogeneity. Patients with similar clinical presentations often display distinct tumor responses to standard of care (SOC) therapies. Genome landscape
Publikováno v:
Primary and Metastatic Liver Tumors ISBN: 9783319919768
Hepatic resection plays a critical role in the multimodality management of various primary and secondary liver malignancies and in many cases represents the only potentially curative intervention. When considering a patient for hepatic resection, thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67f875d6abb6148236c3fd55262e3c4c
https://doi.org/10.1007/978-3-319-91977-5_1
https://doi.org/10.1007/978-3-319-91977-5_1